I am toô, but not because it’s another product launch.

What caught my attention is the foundation behind it.

Before Mint was introduced, Injective had already processed over $6.8B in RWA volume and surpassed $1.1B in native asset issuance. To me, those numbers show that tokenization on Injective has already moved beyond the experimental stage.

That’s why Mint feels like a natural evolution rather than a standalone announcement.

The challenge today isn’t simply putting assets onchain. Many platforms can do that.

The real challenge is making issuance simple enough for institutions while embedding compliance into the process instead of treating it as an afterthought.

That’s exactly what I see with Injective Mint.

By combining issuance, permissions, and regulatory rails into one unified platform, Injective is reducing friction for institutions that want to enter the tokenized asset market.

Looking ahead, I don’t think the winners in tokenization will be the projects that launch the most assets.

They’ll be the ones that make tokenization practical, compliant, and scalable for real-world adoption.

From my perspective, Injective Mint is another step toward that future rather than just another product release.